These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6489421)

  • 1. Effect of food on pharmacokinetics of chlorambucil and its main metabolite, phenylacetic acid mustard.
    Ehrsson H; Wallin I; Simonsson B; Hartvig P; Oberg G
    Eur J Clin Pharmacol; 1984; 27(1):111-4. PubMed ID: 6489421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic basis for the comparative antitumour activity and toxicity of chlorambucil, phenylacetic acid mustard and beta, beta-difluorochlorambucil (CB 7103) in mice.
    Lee FY; Coe P; Workman P
    Cancer Chemother Pharmacol; 1986; 17(1):21-9. PubMed ID: 3698173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetics of chlorambucil and melphalan in man.
    Alberts DS; Chang SY; Chen HS; Larcom BJ; Evans TL
    Recent Results Cancer Res; 1980; 74():124-31. PubMed ID: 7444135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter- and intraindividual differences in oral chlorambucil pharmacokinetics.
    Hartvig P; Simonsson B; Oberg G; Wallin I; Ehrsson H
    Eur J Clin Pharmacol; 1988; 35(5):551-4. PubMed ID: 3069479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of chlorambucil in patients with chronic lymphocytic leukaemia: comparison of different days, cycles and doses.
    Silvennoinen R; Malminiemi K; Malminiemi O; Seppälä E; Vilpo J
    Pharmacol Toxicol; 2000 Nov; 87(5):223-8. PubMed ID: 11129502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-performance liquid chromatographic analysis of chlorambucil tert.-butyl ester and its active metabolites chlorambucil and phenylacetic mustard in plasma and tissue.
    Greig NH; Stahle PL; Shetty HU; Genka S; John V; Soncrant TT; Rapoport SI
    J Chromatogr; 1990 Dec; 534():279-86. PubMed ID: 2094719
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the pharmacokinetics of chlorambucil and prednimustine in patients using a new high-performance liquid chromatographic assay.
    Oppitz MM; Musch E; Malek M; Rüb HP; von Unruh GE; Loos U; Mühlenbruch B
    Cancer Chemother Pharmacol; 1989; 23(4):208-12. PubMed ID: 2924378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolism of deuterated analogues of chlorambucil by the rat.
    Farmer PB; Foster AB; Jarman M; Newell DR; Oddy MR; Kiburis JH
    Chem Biol Interact; 1979 Dec; 28(2-3):211-24. PubMed ID: 549741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can food affect the bioavailability of chlorambucil in patients with haematological malignancies?
    Adair CG; Bridges JM; Desai ZR
    Cancer Chemother Pharmacol; 1986; 17(1):99-102. PubMed ID: 3698184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics of chlorambucil and prednimustine after oral administration.
    Loos U; Musch E; Malek M; Riedel E
    Oncology; 1991; 48(4):334-42. PubMed ID: 1891177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and metabolism of chlorambucil in man: a preliminary report.
    Alberts DS; Chang SY; Chen HS; Larcom BJ; Jones SE
    Cancer Treat Rev; 1979 Jun; 6 Suppl():9-17. PubMed ID: 498174
    [No Abstract]   [Full Text] [Related]  

  • 12. Reactions of {4-[bis(2-chloroethyl)amino]phenyl}acetic acid (phenylacetic acid mustard) with 2'-deoxyribonucleosides.
    Florea-Wang D; Ijäs I; Hakala K; Mattinen J; Vilpo J; Hovinen J
    Chem Biodivers; 2007 Mar; 4(3):406-23. PubMed ID: 17372943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the pharmacokinetics of chlorambucil and prednimustine in man.
    Newell DR; Calvert AH; Harrap KR; McElwain TJ
    Br J Clin Pharmacol; 1983 Feb; 15(2):253-8. PubMed ID: 6849759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and metabolism of chlorambucil in patients with malignant disease.
    McLean A; Woods RL; Catovsky D; Farmer P
    Cancer Treat Rev; 1979 Jun; 6 Suppl():33-42. PubMed ID: 498170
    [No Abstract]   [Full Text] [Related]  

  • 15. Adsorption to human red blood cells of chlorambucil and other biological alkylating agents.
    Linford JH; Hryniuk W; Israels LG
    Biochem Pharmacol; 1969 Oct; 18(10):2723-35. PubMed ID: 5404005
    [No Abstract]   [Full Text] [Related]  

  • 16. The uptake and utilization of chlorambucil by lymphocytes from patients with chronic lymphocytic leukaemia.
    Hill BT; Harrap KR
    Br J Cancer; 1972 Dec; 26(6):439-43. PubMed ID: 4647395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teratogenicity of chlorambucil in rat embryos in vitro.
    Mirkes PE; Greenaway JC
    Teratology; 1982 Oct; 26(2):135-43. PubMed ID: 7157190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship of labeled molecules in the pharmacokinetic study of alkylating agents (chlorambucil, melphalan, mitoclomine) and glycosyl nitrosoureas (RFCNU and RPCNU)].
    Meyniel G; Godenech D
    Nouv Rev Fr Hematol (1978); 1979; Suppl():XXXIII-XXXV. PubMed ID: 545309
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of chlorambucil-tertiary butyl ester, a lipophilic chlorambucil derivative that achieves and maintains high concentrations in brain.
    Greig NH; Daly EM; Sweeney DJ; Rapoport SI
    Cancer Chemother Pharmacol; 1990; 25(5):320-5. PubMed ID: 2306791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced hydrolytic stability and water solubility of an aromatic nitrogen mustard by conjugation with molecular umbrellas.
    Vijayaraghavan S; Jing B; Vrablik T; Chou TC; Regen SL
    Bioconjug Chem; 2003; 14(3):667-71. PubMed ID: 12757393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.